Norway's giant wealth fund touts possibility of Novo Nordisk, Eli Lilly joining the trillion-dollar club

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.Norway's giant wealth fund, the world's largest, touted the possibility that Danish drugmaker Novo Nordisk and U.S. rival Eli Lilly could be on course to become the first healthcare members of the trillion-dollar club.The comments come as the two companies are seen as the primary beneficiaries of skyrocketing demand for diabe ...